CORMORANT ASSET MANAGEMENT, LP – Design Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$83.6M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+19.43%
quarter
Design Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.09% | -500K shares | 6.6M | $16.72 | 5M |
| Q2 2022 | share | Increase | +6.65% | 343.00K shares | -6.28M | $14 | 5.5M |
| Q1 2022 | share | Decrease | -5.21% | -283.45K shares | -33.19M | $16.15 | 5.15M |
| Q4 2021 | share | Increase | +1.41% | 75.60K shares | 37.67M | $21.29 | 5.44M |
| Q3 2021 | share | Decrease | -0.92% | -50K shares | -27.15M | $14.69 | 5.36M |
| Q2 2021 | share | Increase | +5.87% | 300K shares | -40.44M | $19.89 | 5.41M |
| Q1 2021 | share | Increase | 0.00% | 5.11M shares | 146.40M | $29.9 | 5.11M |